FDA Inspection 1330730 — USA-AGP Pharma LLC

USA-AGP Pharma LLC — FEI 3020719811

The FDA completed an inspection of USA-AGP Pharma LLC on Aug 13, 2026 in Garden Grove, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 13, 2026
Fiscal Year
2026
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Garden Grove, CA (United States)

Citations

IDCFRDescription
2284321 CFR 111.70(b)Specifications - components
2284721 CFR 111.70(e)Specifications - finished dietary supplement
2285921 CFR 111.103Written procedures - establish; quality control operations
2288821 CFR 111.210Master manufacturing record - record requirements
2289021 CFR 111.260Batch record - required information

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.